822
Participants
Start Date
April 4, 2022
Primary Completion Date
May 13, 2022
Study Completion Date
May 31, 2022
JT001
Day 1: 600mg, Q12H X 1 day; Day 2\~5: 300mg, Q12H X 4 days
Paxlovid
Day 1\~5: 300 mg of Nirmatrelvir and 100 mg of ritonavir, Q12H X 5 days
Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai
Shanghai Tongren Hospital, Shanghai
Shanghai Public Health Clinical Center, Shanghai
Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai
ShuGuang Hospital, Shanghai
Shanghai Pudong Hospital, Shanghai
Huashan Hospital affiliated to Fudan University, Shanghai
Vigonvita Life Sciences
INDUSTRY